His primary areas of study are Vaccination, Immunology, Pediatrics, Odds ratio and Internal medicine. His specific area of interest is Vaccination, where he studies Influenza vaccine. His studies deal with areas such as Meningitis, Cohort study, Environmental health, Retrospective cohort study and Pneumococcal infections as well as Immunology.
His Pediatrics research is multidisciplinary, relying on both Respiratory tract infections, Epidemiology, Incidence, Younger age and Conjugate vaccine. His studies examine the connections between Odds ratio and genetics, as well as such issues in Confidence interval, with regards to Logistic regression, Asthma and Intensive care medicine. His Internal medicine research includes themes of Diabetes mellitus, Type 2 diabetes, Surgery and Streptococcus pneumoniae.
The scientist’s investigation covers issues in Internal medicine, Vaccination, Pediatrics, Odds ratio and Immunology. Eelko Hak interconnects Diabetes mellitus and Type 2 diabetes in the investigation of issues within Internal medicine. A large part of his Vaccination studies is devoted to Influenza vaccine.
His research integrates issues of Respiratory tract infections, Epidemiology, Asthma, Medical prescription and Cohort in his study of Pediatrics. His Odds ratio study integrates concerns from other disciplines, such as Logistic regression, Surgery, Retrospective cohort study, Pneumonia and Risk factor. Eelko Hak combines subjects such as Incidence, Disease and Streptococcus pneumoniae, Pneumococcal infections with his study of Immunology.
Eelko Hak spends much of his time researching Internal medicine, Pharmacy, Medical prescription, Retrospective cohort study and Influenza vaccine. His Confidence interval, Odds ratio, Hazard ratio and Cohort study study are his primary interests in Internal medicine. His study looks at the relationship between Retrospective cohort study and fields such as Tuberculosis, as well as how they intersect with chemical problems.
As part of his inquiry into Virology, Virus, Immunology and Vaccination, Eelko Hak is doing Influenza vaccine research. In Immunology, Eelko Hak works on issues like Case-control study, which are connected to Research design, Meta-analysis and Logistic regression. His Influenza immunization study in the realm of Vaccination interacts with subjects such as Literature research.
Eelko Hak focuses on Internal medicine, Influenza vaccine, Odds ratio, Immunology and Retrospective cohort study. His work in Internal medicine addresses issues such as Paroxetine, which are connected to fields such as Observational study, Cochrane Library and Anesthesia. Virology and Vaccination are closely tied to his Influenza vaccine research.
His studies in Vaccination integrate themes in fields like Community-acquired pneumonia, Research design, Meta-analysis, Disease and Confounding. His research in Odds ratio intersects with topics in Confidence interval, Proportional hazards model, Obstetrics, Tuberculosis and Cohort. His study on Immunology is mostly dedicated to connecting different topics, such as Case-control study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.
L M A J Muller;K J Gorter;Eelko Hak;W L Goudzwaard.
Clinical Infectious Diseases (2005)
Effectiveness of influenza vaccine in the community-dwelling elderly.
Kristin L. Nichol;James D. Nordin;David B. Nelson;John P. Mullooly.
The New England Journal of Medicine (2007)
Oral Decontamination with Chlorhexidine Reduces the Incidence of Ventilator-associated Pneumonia
Mirelle Koeman;Andre J. A. M. van der Ven;Eelko Hak;Hans C. A. Joore.
American Journal of Respiratory and Critical Care Medicine (2006)
Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
Frans H. Rutten;Nicolaas P. A. Zuithoff;Eelko Hak;Diederick E. Grobbee.
JAMA Internal Medicine (2010)
Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations.
Eelko Hak;James Nordin;Feifei Wei;John Mullooly.
Clinical Infectious Diseases (2002)
Evaluation of impermeable covers for bedding in patients with allergic rhinitis
Ingrid Terreehorst;Eelko Hak;Albert J. Oosting;Zana Tempels-Pavlica.
The New England Journal of Medicine (2003)
Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study
Eelko Hak;Erik Buskens;Gerrit A van Essen;Dinny H de Bakker.
JAMA Internal Medicine (2005)
Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection.
Jan Jelrik Oosterheert;Anton M van Loon;Rob Schuurman;Andy I M Hoepelman.
Clinical Infectious Diseases (2005)
Rationale and design of CAPITA : a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults
Eelko Hak;D E Grobbee;E A M Sanders;T J M Verheij.
Netherlands Journal of Medicine (2008)
Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program.
Eelko Hak;Y Schönbeck;H De Melker;G A Van Essen.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: